IL236265A - METHOD FOR PREPARING TRIAZULOPYRIDINES - Google Patents

METHOD FOR PREPARING TRIAZULOPYRIDINES

Info

Publication number
IL236265A
IL236265A IL236265A IL23626514A IL236265A IL 236265 A IL236265 A IL 236265A IL 236265 A IL236265 A IL 236265A IL 23626514 A IL23626514 A IL 23626514A IL 236265 A IL236265 A IL 236265A
Authority
IL
Israel
Prior art keywords
preparing substituted
substituted triazolopyridines
triazolopyridines
preparing
substituted
Prior art date
Application number
IL236265A
Other languages
English (en)
Hebrew (he)
Other versions
IL236265A0 (en
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IL236265A0 publication Critical patent/IL236265A0/en
Publication of IL236265A publication Critical patent/IL236265A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL236265A 2012-07-10 2014-12-15 METHOD FOR PREPARING TRIAZULOPYRIDINES IL236265A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (2)

Publication Number Publication Date
IL236265A0 IL236265A0 (en) 2015-02-26
IL236265A true IL236265A (en) 2017-07-31

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
IL236265A IL236265A (en) 2012-07-10 2014-12-15 METHOD FOR PREPARING TRIAZULOPYRIDINES

Country Status (24)

Country Link
US (1) US9388177B2 (enExample)
EP (1) EP2872506A1 (enExample)
JP (1) JP6238979B2 (enExample)
KR (1) KR20150040845A (enExample)
CN (1) CN104603136B (enExample)
AP (1) AP3778A (enExample)
AU (1) AU2013289381A1 (enExample)
BR (1) BR112015000308A2 (enExample)
CA (1) CA2878481A1 (enExample)
CL (1) CL2015000038A1 (enExample)
CO (1) CO7160002A2 (enExample)
CR (1) CR20150006A (enExample)
DO (1) DOP2015000007A (enExample)
EA (1) EA027544B1 (enExample)
HK (1) HK1206731A1 (enExample)
IL (1) IL236265A (enExample)
IN (1) IN2015DN00085A (enExample)
MX (1) MX2015000348A (enExample)
NZ (1) NZ703020A (enExample)
PE (1) PE20150354A1 (enExample)
PH (1) PH12015500061A1 (enExample)
SG (1) SG11201408419QA (enExample)
TN (1) TN2015000008A1 (enExample)
WO (1) WO2014009219A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014195276A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
DK3008062T3 (en) * 2013-06-11 2017-06-12 Bayer Pharma AG PRODRUG DERIVATIVES OF SUBSTITUTED TRIAZOLOPYRIDINES
US20160128988A1 (en) 2013-06-11 2016-05-12 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
US11208696B2 (en) 2015-04-17 2021-12-28 Netherlands Translational Research Center B.V. Prognostic biomarkers for TTK inhibitor chemotherapy
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009812A1 (en) * 2001-10-05 2005-01-13 Takuya Seko Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
CA2566158A1 (en) * 2004-05-14 2005-11-24 Abbott Laboratories Kinase inhibitors as therapeutic agents
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
JP2008515874A (ja) * 2004-10-07 2008-05-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 抗菌薬
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
US7557104B2 (en) * 2006-06-06 2009-07-07 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
MX2009002171A (es) 2006-08-30 2009-05-28 Cellzome Ltd Derivados de triazol como inhibidores de cinasas.
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
AU2008277628B2 (en) 2007-07-18 2012-03-15 Novartis Ag Bicyclic heteroaryl compounds and their use as kinase inhibitors
CN103298814A (zh) 2007-08-23 2013-09-11 阿斯利康(瑞典)有限公司 作为治疗增殖性疾病的ttk/mps1抑制剂的2-苯胺基嘌呤-8-酮
KR20100075881A (ko) 2007-08-31 2010-07-05 메르크 세로노 에스. 에이. 트리아졸로피리딘 화합물 및 ａｓｋ 저해제로서 이의 용도
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
US8530689B2 (en) * 2008-05-05 2013-09-10 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
EP2303890A4 (en) * 2008-06-19 2012-04-11 Progenics Pharm Inc INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
CA2751517A1 (en) 2009-02-13 2010-08-19 Fovea Pharmaceuticals [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
EP2424537B1 (en) 2009-04-29 2015-07-08 Bayer Intellectual Property GmbH Substituted imidazoquinoxalines
CA2763900A1 (en) * 2009-06-05 2010-12-09 Cephalon, Inc. Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
EP2473498A1 (en) 2009-09-04 2012-07-11 Bayer Pharma Aktiengesellschaft Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343295A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
AU2012244859B2 (en) * 2011-04-21 2017-06-08 Bayer Intellectual Property Gmbh Triazolopyridines
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
MX2015000348A (es) 2015-04-14
US9388177B2 (en) 2016-07-12
PE20150354A1 (es) 2015-03-21
KR20150040845A (ko) 2015-04-15
CO7160002A2 (es) 2015-01-15
US20150148542A1 (en) 2015-05-28
PH12015500061A1 (en) 2015-03-02
BR112015000308A2 (pt) 2017-06-27
AU2013289381A1 (en) 2015-01-22
JP2015523372A (ja) 2015-08-13
SG11201408419QA (en) 2015-01-29
AP2014008177A0 (en) 2014-12-31
CA2878481A1 (en) 2014-01-16
CR20150006A (es) 2015-02-16
IL236265A0 (en) 2015-02-26
NZ703020A (en) 2017-08-25
CL2015000038A1 (es) 2015-03-13
IN2015DN00085A (enExample) 2015-05-29
CN104603136B (zh) 2017-06-27
CN104603136A (zh) 2015-05-06
TN2015000008A1 (en) 2016-06-29
WO2014009219A1 (en) 2014-01-16
HK1206731A1 (en) 2016-01-15
EA201590116A1 (ru) 2015-07-30
EP2872506A1 (en) 2015-05-20
AP3778A (en) 2016-08-31
EA027544B1 (ru) 2017-08-31
JP6238979B2 (ja) 2017-11-29
DOP2015000007A (es) 2015-02-15

Similar Documents

Publication Publication Date Title
ZA201501833B (en) Method for obtaining 1-kestone
GB201223172D0 (en) Method
GB201212937D0 (en) Method
GB201212932D0 (en) Method
GB201212934D0 (en) Method
PL2817775T3 (pl) Sposób pomiaru oglądalności
GB201213636D0 (en) Method
GB201222693D0 (en) Novel method
GB201210858D0 (en) Method
SG11201407032WA (en) Method
GB201218570D0 (en) Method
IL236265A (en) METHOD FOR PREPARING TRIAZULOPYRIDINES
GB201202198D0 (en) Method
EP2915817A4 (en) PROCESS FOR THE PREPARATION OF EXENATIDE
SG11201501567QA (en) Method for producing 7-octenal
EP2818476A4 (en) PROCESS FOR PREPARING 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-L-FURANIDOSE
GB201223316D0 (en) Method
GB201211393D0 (en) Method
GB201222737D0 (en) Method
GB201217688D0 (en) Method
GB201214029D0 (en) method
GB201210147D0 (en) Method
GB201201332D0 (en) Method
IL238934A (en) Methods for making phenyloxymethyl-nitro-imidazole derivatives
IL234526A (en) METHOD FOR PRODUCING DIETHINE TETRACARBOXIMIDES

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees